Kenya - English - Pharmacy and Poisons Board

dolutegravir sodium - film-coated tablet - dolutegravir sodium tablet for oral suspension… - dolutegravir

Kenya - English - Pharmacy and Poisons Board

lupin limited 3rd floor, kalpataru inspire, off w. e. highway, - dolutegravir, lamivudine and tenofovir disoproxil… - tablet - dolutegravir, lamivudine and tenofovir disoproxil… - dolutegravir

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

macleods pharmaceuticals limited, india - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - oral tablet - dolutegravir 50mg, lamivudine 300mg and tenofovir disoproxil fumerate 300mg

Kenya - English - Pharmacy and Poisons Board

dolutegravir sodium. - tablet - : each film coated tablet contains: dolutegravir… - dolutegravir

Kenya - English - Pharmacy and Poisons Board

cipla limited cipla house, peninsula business park, ganpatrao - dolutegravir (as sodium) , lamivudine and… - film-coated tablet - dolutegravir (as sodium): 50 mg , lamivudine: 300… - lamivudine and tenofovir disoproxil

Kenya - English - Pharmacy and Poisons Board

cipla quality chemical industries limited plot 1 - 7, 1st ring road, luzira industrial - dolutegravir sodium, lamivudine and tenofovir… - tablet - dolutegravir sodium 50mg, lamivudine 300mg and… - direct acting antivirals

Kenya - English - Pharmacy and Poisons Board

laurus labs limited 2nd floor, serene chambers, road no.-7 banjara - dolutegravir, lamivudine and tenofovir disoproxil… - film-coated tablet - dolutegravir 50mg, lamivudine 300mg and tenofovir… - antivirals for systemic use

Kenya - English - Pharmacy and Poisons Board

dolutegravir, emtricitabine and tenofovir… - film-coated tablet - dolutegravir, emtricitabine and tenofovir… - antivirals for systemic use: combinations of

United States - English - NLM (National Library of Medicine)

viiv healthcare company - dolutegravir sodium (unii: 1q1v9v5wyq) (dolutegravir - unii:dko1w9h7m1), rilpivirine hydrochloride (unii: 212wax8kdd) (rilpivirine - unii:fi96a8x663) - dolutegravir 50 mg - juluca is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (hiv-1 rna less than 50 copies per ml) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of juluca. juluca is contraindicated in patients:    •    with previous hypersensitivity reaction to dolutegravir or rilpivirine [see warnings and precautions (5.1)] .    •    receiving dofetilide due to the potential for increased dofetilide plasma concentrations and the risk for serious and/or life-threatening events [see drug interactions (7)] .    •    receiving other coadministered drugs in table 1 that significantly decrease rilpivirine plasma concentrations [see drug interactions (7), clinical pharmacology (12.3)] . drug class contraindicated drugs in class clinical comment antia

Kenya - English - Pharmacy and Poisons Board

cipla limited cipla house, peninsula business park, ganpatrao - dolutegravir sodium and lamivudine - tablet - 50 mg of dolutegravir (equivalent to 52.6 mg… - antivirals for systemic use: combinations of